Results 11 to 20 of about 1,076,076 (217)

OXA-484, an OXA-48-Type Carbapenem-Hydrolyzing Class D β-Lactamase From Escherichia coli

open access: yesFrontiers in Microbiology, 2021
OXA-48-like carbapenemases are among the most frequent carbapenemases in Gram-negative Enterobacterales worldwide with the highest prevalence in the Middle East, North Africa and Europe.
Sara Riedel-Christ   +2 more
exaly   +4 more sources

OXA 48 Mediated Ceftazidime Avibactam Resistance Is Associated with Evolutionary Trade Offs [PDF]

open access: yesmSphere, 2019
Infections due to carbapenemase-producing Gram-negative pathogens are associated with limited treatment options and consequently lead to increased mortality and morbidity.
Thomassen, A.M.   +11 more
core   +5 more sources

Discovery of bla(OXA-199), a chromosome-based bla(OXA-48)-like variant, in Shewanella xiamenensis. [PDF]

open access: yesPLoS ONE, 2012
INTRODUCTION: bla(OXA-48) is a globally emerging carbapenemase-encoding gene. The progenitor of bla(OXA-48) appears to be a Shewanella species. The presence of the bla(OXA-48)-like gene was investigated for two Shewanella xiamenensis strains.
Zhiyong Zong, Zong Zhiyong
core   +2 more sources

Genetic characteristics of OXA-48-producing Enterobacterales from China

open access: yesJournal of Global Antimicrobial Resistance, 2021
In China, OXA-48-producing Enterobacterales have been identified sporadically, causing small-scale regional outbreaks. This study investigated the molecular epidemiology, transmission and evolution of OXA-48-producing Enterobacterales and pOXA48 from mainland China.We conducted a multicentre resistance monitoring project from 2013-2018.
Lifeng Wang   +3 more
openaire   +4 more sources

Arising Prevalence of OXA-48 producer Escherichia coli and OXA-48 with NDM co-producer Klebsiella pneumoniae Strains [PDF]

open access: yesRevista Romana de Medicina de Laborator, 2019
Abstract Background/aim : This prospective study aimed to determine the presence of the most common carbapenemase genes, blaOXA-48, blaKPC, blaIMP, blaVIM and blaNDM on carbapenem resistant clinical K.pneumoniae and E.coli isolates. Materials and methods :
Uskudar-Guclu Aylin   +4 more
openaire   +2 more sources

Emergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan

open access: yesPLOS ONE, 2015
The isolation of OXA-48-producing Enterobacteriaceae has increased dramatically in Mediterranean countries in the past 10 years, and has recently emerged in Asia. Between January 2012 and May 2014, a total of 760 carbapenem non-susceptible Klebsiella pneumoniae (CnSKP) isolates were collected during a Taiwan national surveillance.
Ling Ma   +7 more
core   +6 more sources

Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France [PDF]

open access: yesClinical Microbiology and Infection, 2014
We characterized 53 OXA-48-producing Klebsiella pneumoniae (OXA-48-Kp) isolated between 2011 and 2013 in 21 French hospitals. All the isolates were genotyped using MLST and PFGE and the population structure of the species was determined by a nucleotide-based analysis of the entire K. pneumoniae MLST database.
Liapis, E.   +14 more
openaire   +4 more sources

One-step differential detection of OXA-48-like variants using high-resolution melting (HRM) analysis [PDF]

open access: yesAntibiotics, 2020
OXA-48-like carbapenemase gene remains a hidden threat, as different OXA-48 variants have varying presentations of susceptibility to antibiotics that might affect the treatment decisions.
Sasheela Sri La Sri Ponnampalavanar   +13 more
core   +3 more sources

Detection of OXA-48-Carbapenemase-Producing Enterobacteriaceae using ChromID OXA-48 in Critical Care Patients in Egypt

open access: yesJournal of Pure and Applied Microbiology, 2017
Carbapenems are a class of beta-lactam antibiotics with broad spectrum of activity. They are often considered as a last resort in treatment of infections caused by multidrug resistant organisms. Carbapenemase-producing Enterobacteriaceae (CPE) have been reported worldwide.
Basma A. El Awady   +3 more
openaire   +3 more sources

Cefiderocol Comparative Resistance and Clinical Predictors in CRE-BSI: Data from an OXA-48-Endemic Region with Rising OXA-48/NDM Coproducers. [PDF]

open access: yesAntibiotics (Basel)
Background/Objectives: Bloodstream infections (BSIs) caused by carbapenem-resistant Enterobacterales (CREs) are a growing public health threat due to limited therapeutic options and high mortality. In Turkey, oxacillinase-48 (OXA-48) producers predominate, while OXA-48/New Delhi metallo-β-lactamase (NDM) co-producers are increasingly detected. Although
Dumlu R, Mert A.
europepmc   +4 more sources

Home - About - Disclaimer - Privacy